An antimicrobial stewardship team is auditing the appropriateness of targeted therapies for various complex infections. Match each specific patient scenario and pathogen profile below with its single most appropriate targeted treatment strategy based on current clinical guidelines.
- A 29-year-old pregnant woman at 24 weeks gestation with secondary syphilis and a documented IgE-mediated anaphylaxis to penicillin.Inpatient penicillin desensitization followed by intravenous penicillin G
- A 62-year-old man with native valve endocarditis due to Enterococcus faecalis that is ampicillin-susceptible but exhibits high-level gentamicin resistance.Combination therapy with intravenous ampicillin and intravenous ceftriaxone
- A 68-year-old man with Listeria monocytogenes meningitis and a documented history of severe anaphylaxis to all beta-lactam antibiotics.Intravenous trimethoprim-sulfamethoxazole
- A 54-year-old woman with profound neutropenia presenting with pleuritic chest pain; chest imaging reveals a nodule with a surrounding ground-glass halo, and serum galactomannan is markedly elevated.Intravenous voriconazole
Cevap
Each clinical scenario is matched with its definitive guideline-recommended targeted therapy, factoring in specific resistance patterns, allergies, and patient characteristics.
Each matching pair correctly aligns a complex infectious disease scenario with its definitive, guideline-supported treatment exception. The pregnant patient with syphilis requires penicillin desensitization. The patient with HLAR Enterococcus endocarditis requires dual beta-lactam therapy (ampicillin and ceftriaxone). The penicillin-allergic patient with Listeria requires trimethoprim-sulfamethoxazole. The patient with invasive aspergillosis requires voriconazole.
Adım Adım Çözüm
Anahtar Kavram
Targeted antimicrobial therapy for complex systemic infections requires specific deviations from standard therapy based on patient factors (e.g., pregnancy, severe allergies) and specific pathogen resistance mechanisms.
Tahmini Süre:2m 0s